US 12201591
Sustained release compositions of endoxifen
granted A61KA61K31/135A61K31/138
Quick answer
US patent 12201591 (Sustained release compositions of endoxifen) held by ATOSSA THERAPEUTICS, INC. expires Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ATOSSA THERAPEUTICS, INC.
- Grant date
- Tue Jan 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 31
- CPC classes
- A61K, A61K31/135, A61K31/138, A61K31/343, A61K31/4525